01 1Viatris
01 1GATIFLOXACIN
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-30
Pay. Date : 2013-04-12
DMF Number : 17013
Submission : 2003-12-10
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is GATIFLOXACIN, with a corresponding US DMF Number 17013.
Remarkably, this DMF maintains an Active status since its submission on December 10, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 30, 2013, and payment made on April 12, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
